George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 976.00
Bid: 981.00
Ask: 983.00
Change: 1.00 (0.10%)
Spread: 2.00 (0.204%)
Open: 970.00
High: 991.00
Low: 970.00
Prev. Close: 975.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

30 Nov 2017 07:00

RNS Number : 9120X
CVS Group plc
30 November 2017
 

30 November 2017

CVS Group plc

("CVS" or the "Group")

 

AGM Statement

 

CVS, the UK's leading integrated provider of veterinary services, is holding its AGM at 11.00 a.m. today at which Richard Connell, Chairman, will provide the following update to shareholders:

 

"The Board is pleased to announce that in the four month period ended 31 October 2017 the Group's total sales grew by 20.6% and like-for-like sales1 grew by 4.3% compared to the same period last year.

 

The strong growth in sales of Animed Direct, which we noted in our last results statement, has continued. Excluding Animed Direct, like-for-like sales for the Group grew by 1.5% which, while a slower growth rate than in other recently reported periods, is measured against particularly strong comparators in the previous year which moderate as the current financial year progresses. The like-for-like trends have shown more variance both within and between months than in prior years, making it harder to identify particular trends. The Board believes that the slower like-for-like growth probably reflects the impact on consumers of the greater general uncertainty widely evident in the UK economy and some shortage of clinicians in the UK. Customer loyalty remains high and our healthy pet scheme memberships continue to show excellent growth, at a run-rate in line with the 20%+ level reported at our most recent year end.

 

For many years it has been challenging to recruit veterinary surgeons in the UK. In spite of the fact that CVS believes it is able to offer new recruits the broadest range of career paths and opportunities within the UK industry, we note that these challenges have increased since the vote to leave the European Union. The Group intends to implement a number of measures to encourage more veterinary surgeons and nurses to work for CVS. These measures will include increasing some salaries by more than inflation as well as improving flexible working opportunities. It is intended that any increases in salaries will be funded through price increases.

 

Market consolidation continues and the higher level of acquisition activity evident during our most recent reporting periods has continued. The Group continues to see a large number of opportunities, both in the UK and the Netherlands and anticipates that these markets will remain particularly active. The integration of our recently acquired assets provides strong underpinning for the Group's overall growth expectations as well as affording the opportunity to derive increased benefits from synergies and scale.

 

Since the start of the current financial year on 1 July 2017, the Group has made a total of 13 acquisitions of 21 surgeries bringing the total number of surgeries to 444. The acquisitions were:

 

Practice name

No. ofsites

Main locations

Region & Country

Business

Cundall & Duffy

1

Scarborough

N.E. England

Small & farm animal

StruleVet Services

2

Omagh and County Tyrone

Northern Ireland

Small & farm animal

DierenkliniekWolvega

1

Wolvega

The Netherlands

Small animal

B & W Equine

5

Breadstone, Cardiff, Failand, Stretcholt and Willesley

S.W. England;S. Wales

Equine

Aire

1

Leeds

N England

Small animal, farm animal & equine

DierenkliniekEmmeloord

1

Emmeloord

The Netherlands

Equine

All CreaturesVeterinary Centre

1

Warrington

N.W. England

Small animal

AcornVeterinary Centre

1

Studley

C. England

Small animal

Three ValleysVeterinary

2

Fivemiletown, Irvinestown

Northern Ireland

Small & farm animal

DierenkliniekVrieselaar

1

Lemmer

The Netherlands

Small animal

Buchan Vets

3

Strichen, Peterhead, Fraserburgh

Scotland

Small animal, farm animal & equine

AshburnVeterinary Centre

1

Knighton

S. Wales

Small & farm animal

MS Vets

1

Reading

S.E. England

Small animal

 

 

The total consideration for the above acquisitions was approximately £20.0m.

 

The acquisition of further practices in the UK has continued the geographic development of the Group across the country and has further developed the large animal and equine as well as the small animal businesses. The acquisitions in Northern Ireland bring our total number of sites there to eight whilst the acquisitions in the Netherlands bring our total there to 12. Of particular note is the development of the equine business with the acquisition of B&W Equine in the UK and of Dierenkliniek Emmeloord, our first equine business in the Netherlands.

 

The pipeline of acquisitions remains strong and CVS expects to continue to complete acquisitions in the UK and the Netherlands throughout this year and beyond. Our diverse, integrated model means that acquired businesses not only contribute towards our continuing success, but also benefit from being part of a larger integrated group better able to serve customers' needs."

 

Notes: 

1. Like-for-like sales data comprise revenue generated from all operations compared to the prior year and includes revenue from acquired businesses with effect from the date and month in which it was acquired during the previous year

 

 

Contacts:

CVS Group plc 01379 644 288

Simon Innes, Chief Executive

Nick Perrin, Financial Director

 

N+1 Singer (Nominated Adviser & Broker) 020 7496 3000

Aubrey Powell

Liz Yong

James Hopton

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBIBDBUDDBGRC
Date   Source Headline
11th Apr 20245:48 pmRNSStandard form for notification of major holdings
8th Apr 20247:00 amRNSNotice of Cyber Incident
28th Mar 20244:07 pmRNSExercise of Options and Total Voting Rights
12th Mar 20248:06 amRNSResponse to CMA update
29th Feb 20247:00 amRNSExercise of Options and Total Voting Rights
29th Feb 20247:00 amRNSInterim Results
5th Feb 202411:02 amRNSStandard form for notification of major holdings
31st Jan 20247:00 amRNSExercise of Options and Total Voting Rights
29th Jan 20243:41 pmRNSPDMR Dealing
25th Jan 20247:00 amRNSHalf year Trading Update
19th Jan 20242:24 pmRNSExercise of SAYE Options and PDMR Dealing
12th Jan 20241:56 pmRNSExercise of SAYE Options and PDMR Dealing
12th Jan 20247:00 amRNSBlock Listing Interim Review
5th Jan 20242:44 pmRNSReplacement of Director/PDMR Shareholding
5th Jan 202410:25 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options and Total Voting Rights
22nd Dec 20237:48 amRNSBlock Listing Application
30th Nov 20237:00 amRNSExercise of Options and Total Voting Rights
29th Nov 20233:43 pmRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement and Trading Update
24th Nov 20233:56 pmRNSGrant of Options under CVS Group plc
3rd Nov 20237:05 amRNSPosting of Annual Report and Notice of AGM
31st Oct 20234:46 pmRNSExercise of Options and Total Voting Rights
27th Oct 20237:00 amRNSDirectorate Change
13th Oct 20235:21 pmRNSConfirmation of dividend dates
9th Oct 20232:58 pmRNSExercise of Options, PDMR Dealing, EBT and TVR
29th Sep 20237:00 amRNSExercise of Options and Total Voting Rights
21st Sep 20237:00 amRNSFinal results for the year ended 30 June 2023
7th Sep 202310:50 amRNSResponse to CMA review into veterinary market
31st Aug 20237:00 amRNSExercise of Options and Total Voting Rights
31st Jul 20237:00 amRNSTotal Voting Rights
27th Jul 20237:00 amRNSTrading update, AU expansion and UK acquisitions
12th Jul 20237:00 amRNSBlock Listing Interim Review and TVR Update
30th Jun 20237:00 amRNSExercise of Options and Total Voting Rights
22nd Jun 20237:00 amRNSDirectorate Change
31st May 20237:00 amRNSExercise of Options and Total Voting Rights
12th May 20234:41 pmRNSStandard form for notification of major holdings
5th May 20238:53 amRNSBlock Listing Application
2nd May 20237:00 amRNSTotal Voting Rights
31st Mar 20231:39 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSTotal Voting Rights
10th Mar 202310:37 amRNSExercise of SAYE Options, PDMR Dealing and TVR
28th Feb 20237:00 amRNSExercise of Options and Total Voting Rights
24th Feb 20237:00 amRNSInterim Results
2nd Feb 20234:42 pmRNSExercise of Options and Total Voting Rights
26th Jan 20237:00 amRNSHalf year Trading Update
11th Jan 20234:31 pmRNSBlock Listing Interim Review and TVR Update
10th Jan 202312:24 pmRNSExercise of SAYE Options and PDMR Dealing
30th Dec 20227:00 amRNSExercise of Options and Total Voting Rights
20th Dec 20224:38 pmRNSExercise of Options and PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.